Financial Performance - The company's basic earnings per share decreased by 38.46% to 0.1600 yuan in Q1 2025 compared to Q1 2024, which was 0.2600 yuan [1] - Operating revenue dropped by 37.15% to 4.678 billion yuan in Q1 2025 from 7.443 billion yuan in Q1 2024 [1] - Net profit fell by 39.47% to 0.46 billion yuan in Q1 2025, down from 0.76 billion yuan in Q1 2024 [1] - The return on equity decreased by 40.11% to 1.06% in Q1 2025 from 1.77% in Q1 2024 [1] Shareholder Structure - The top ten unrestricted shareholders hold a total of 12,516.04 million shares, accounting for 42.95% of the circulating shares, with a change of 30,000 shares from the previous period [1] - China Everbright Medical Health Industry Co., Ltd. remains the largest shareholder with 4,187.64 million shares, representing 14.37% of total share capital [2] - New entrant Shenzhen New Industry Venture Capital Co., Ltd. holds 162.00 million shares, accounting for 0.56% of total share capital [2] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [3]
嘉事堂:2025一季报净利润0.46亿 同比下降39.47%